Table 2:
Cumulative risk of diagnosis in the first 24 months’ postpartum for specific
Total | Number of events postpartum | %a | HDP | Non-HDP | %b among exposed | %b among unexposed | |
---|---|---|---|---|---|---|---|
Heart failure | 119368 | 202 | 0.2 | 14627 | 104741 | 0.6 | 0.2 |
Ischemic heart disease | 119364 | 121 | 0.2 | 14625 | 104739 | 0.3 | 0.1 |
Cerebrovascular
disease/stroke |
119231 | 443 | 0.5 | 14604 | 104627 | 0.8 | 0.4 |
Arrhythmia/cardiac
arrest |
119344 | 151 | 0.2 | 14619 | 104725 | 0.2 | 0.2 |
Cardiomyopathy | 119345 | 213 | 0.2 | 14620 | 104725 | 0.6 | 0.2 |
Severe cardiac disease (heart failure, stroke, or cardiomyopathy) | 119124 | 741 | 0.8 | 14582 | 104542 | 1.6 | 0.7 |
New chronic hypertension (43+ days after delivery) b | 110761 | 1662 | 2.1 | 9299 | 101462 | 9.7 | 1.5 |
Data source: Maine Health Data Organization’s All Payer Claims Data
HDP=hypertensive disorder of pregnancy
Cumulative risk by 24 months. Censoring events were loss of health insurance coverage or start of the next pregnancy, whichever was earlier. Each model excluded records with any diagnosis before pregnancy of the cardiovascular conditions being examined postpartum, and records with gestational age (<20 weeks), non-Maine residence, multifetal gestation, those with implausible time to next pregnancy (<60 days), and those without health insurance during pregnancy through the first 2 months’ postpartum.
Hypertension diagnoses in the first 42 days’ postpartum were not included as chronic hypertension outcomes, as these were included in the definition of hypertensive disorders of pregnancy.